the Federal Minister of health, Jens Spahn (CDU) called for by the manufacturer of the corona drug Remdesivir despite a large-scale purchase, the United States continued ability to supply. He was waiting by the pharmaceutical company Gilead Sciences, “that Germany and Europe are supplied when it comes to such a drug,” said the CDU politician on Thursday in the ZDF-“morning magazine”. The need for the coming weeks Spahn looks to be already secured. In the Central pharmacy of the Federal government there are appropriate reserves.
The American government has secured a large part of the to September is the targeted production amount of Remdesivir. According to the American Ministry of health, the purchase of active ingredient, it was agreed doses for more than 500,000 treatments. This corresponds to 100 percent of the planned production amount for the month of July and 90 percent for August and September.
Remdesivir is considered to be one of the most promising drugs against the lung disease Covid-19 – at least in severely ill patients. Just last week, the European medicines recommended Agency EMA approval for the funds, subject to conditions in Europe. A decision by the EU Commission is expected this week. Remdesivir was originally developed for the treatment of Ebola, shown here is but a to little effect. It is not yet approved in any country in the world fully as a drug.
